Remove tag pharmaceutical-waste
article thumbnail

STAT+: Pharmalittle: Vertex exec says prices for gene therapies are ‘in the ballpark’; insulin access in poor countries remains spotty

STAT News

… Multimillion-dollar prices for a rival’s treatments with the potential to cure rare diseases are “in the right ballpark,” according to Stuart Arbuckle, chief operating officer at Vertex Pharmaceuticals, which is preparing to market its own treatment for sickle-cell disease , Bloomberg News tells us. Even

article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products. Here’s how applying automaton in pharmaceutical labs can help address these.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH)

Rethinking Clinical Trials

The International Council for Harmonisation of Technical Requirements for Human Use (ICH) is a unique harmonization organization involving regulators and the pharmaceutical industry. It would be such a waste of valuable data, valuable approaches, and valuable infrastructure to not embed clinical trials effectively into health care systems.

article thumbnail

Grand Rounds August 18, 2023: Opportunities to Improve Clinical Trials: Draft Revision of the ICH Good Clinical Practice Guideline (E6R3) (Prof Sir Martin Landray, FMedSci; M. Khair ElZarrad, PhD, MPH; Adrian F. Hernandez, MD, MHS)

Rethinking Clinical Trials

The International Council for Harmonisation of Technical Requirements for Human Use (ICH) is a unique harmonization organization involving regulators and the pharmaceutical industry. It would be such a waste of valuable data, valuable approaches, and valuable infrastructure to not embed clinical trials effectively into health care systems.

article thumbnail

Novartis’ $2 Million Gene Therapy Zolgensma Shows ‘Remarkable’ Results and Offers Hope for Children with SMA

XTalks

SMA is a rare genetic condition that leads to a loss of motor neurons that results in progressive muscle weakness and wasting, paralysis and, when left untreated in its most severe form, breathing difficulties leading to permanent ventilation or death for most patients by the age of two. With a price tag of over $2.5

article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.

Marketing 101
article thumbnail

Tackling the Challenges of Limited Resources During a Pandemic

The Pharma Data

The Solution: Using small, flexible liquid handling solutions that do not depend on disposable tips, and can virtually eliminate reagent waste due to excess dead volume empowers laboratory managers to benefit from the advantages of automation and decrease dependence on scarce resources. The lab’s goal is the. As the race for an.

Reagent 52